Navigation Links
China PharmaHub Reviews 2010 and Recent Accomplishments
Date:3/24/2011

BOSTON, March 24, 2011 /PRNewswire/ -- China PharmaHub Corp. (OTC Bulletin Board Symbol: CPHB), a biopharmaceutical acquisition and development company, today reviewed its 2010 and recent achievements and provided key corporate goals for 2011.

(Logo: https://photos.prnewswire.com/prnh/20100907/LA60053LOGO)

"In 2010, we built the foundations of China PharmaHub as a global company with multiple exclusive licensing products addressing existing multibillion dollar markets," said China PharmaHub CEO Richard Lui. "We took the company public through a merger with an existing public company, opened a second office in Boston and built a presence in China. In addition, we executed on our corporate strategy, securing a combination of in-licensing agreements and exclusive distribution agreements and creating project-specific subsidiaries, working towards becoming a central hub for the acquisition and/or licensing, development, and commercialization of biopharmaceutical products in the U.S. and China."

Mr. Lui continued, "We are dedicated to continuing to secure similar types of arrangements and establishing more product-focused subsidiaries in 2011. We recently signed an exclusive licensing agreement with the University of California for a universal donor blood product, an agreement that showcases the strengths of the China PharmaHub business model and our ability to partner with premier research institutes, and which also will strengthen our intellectual property position. Looking ahead, through our new subsidiary CPC NuLife, we will be working towards bringing CPC001, an irradiated microsphere device for liver cancer, towards commercialization, with regulatory submissions planned shortly and a pivotal trial expected to begin before the end of this year. In addition, we will begin commercializing several ready-to-market products under our collaborations, including the Illumibr
'/>"/>

SOURCE China PharmaHub Corp.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. ACT to Be Issued Broad Patent for Human ES Cell-derived RPE Cells in China
2. China PharmaHub In-Licenses Universal Donor Red Blood Cells Technology Exclusively From University of California, San Diego
3. China-Biotics Expands Product Supplied to Bright Dairy
4. Huifeng Bio-Pharmaceutical Technology, Inc. to Present at the 2011 Rodman & Renshaw Annual China Investment Conference in Shanghai
5. China Cord Blood Corporation Reports Third Quarter and First Nine Months of Fiscal 2011 Financial Results
6. ShengdaTech to Present at Rodman & Renshaw Annual China Investment Conference in Shanghai
7. China Cord Blood Corporation Forms Zhejiang Subsidiary
8. China Cord Blood Corporation Announces Results of 2010 Annual General Meeting
9. China Cord Blood Corporation to Announce Third Quarter Fiscal 2011 Financial Results
10. China-Biotics to Report Fiscal Year 2011 Third Quarter Financial Results on February 9
11. China-Biotics, Inc. Provides Preliminary FY2011Third Quarter Revenue
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... July 29, 2015 /PRNewswire/ - BioAmber Inc. (NYSE: BIOA ... Company,s Chief Financial Officer has resigned.  The Company has ... Officer who retired in December 2014, as full time ... permanent successor.     Andy Ashworth began ... ensure a smooth transition.  Andy was the Company,s CFO ...
(Date:7/29/2015)... 2015 Research and ... of the "Global Biosimilars Market, 2015 - ... The Global Biosimilars Market, 2015 - 2025, report ... biosimilars market. With the blockbuster biologics losing patent ... biosimilars are being viewed as viable substitutes to ...
(Date:7/29/2015)... July 29, 2015  Pfenex Inc. (NYSE MKT: PFNX) ... will be released on Thursday, August 13, 2015, before ... Pfenex management will host a conference call to discuss ... press release outlining the financial results and business update ... Please call 1-866-376-8058 (US) or 1-412-542-4131 (international) and ...
(Date:7/29/2015)... 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS ... an optimized Erk inhibitor molecule for development, thus ... a new class of potential cancer therapies. ... target for therapeutic intervention in cancer. Recently approved ... for B-Raf and Mek inhibitors. Erk inhibitors may ...
Breaking Biology Technology:BioAmber Announces Change in Chief Financial Officer 2BioAmber Announces Change in Chief Financial Officer 3Global Biosimilars Market to 2025: Monoclonal Antibodies (mAbs), Insulin, Interferons, G-CSF/ GM-CSF, Erythropoietins and Others 2Global Biosimilars Market to 2025: Monoclonal Antibodies (mAbs), Insulin, Interferons, G-CSF/ GM-CSF, Erythropoietins and Others 3Pfenex To Report Second Quarter 2015 Results and Provide Business Update on Thursday, August 13, 2015 2Aeterna Zentaris Announces Optimized Erk Inhibitor Compounds For Further Development 2Aeterna Zentaris Announces Optimized Erk Inhibitor Compounds For Further Development 3
... The streaming of real-time information across your field of vision ... a prototype contact lens that could potentially provide the wearer ... today, 22 November, in IOP Publishing,s Journal of Micromechanics ... demonstrated its safety by testing it on live eyes. There ...
... Trieste (Italy), November 21, 2011. CNR Rao, Linus Pauling ... Center for Advanced Scientific Research and immediate past president ... world, has been named the winner of the 2011 ... which is designed to give international recognition and visibility ...
... A program co-funded by the Air Force Office of Scientific Research ... Inventions of 2011. Drs Ali Aliev, Yuri Gartstein ... have succeeded in producing what is technically referred to as the ... some in the popular press have termed it: an ,invisibility cloak,." ...
Cached Biology Technology:Terminator-style info-vision takes step towards reality 2CNR Rao wins 2011 Ernesto Illy Trieste Science Prize 2CNR Rao wins 2011 Ernesto Illy Trieste Science Prize 3CNR Rao wins 2011 Ernesto Illy Trieste Science Prize 4
(Date:7/9/2015)... 9, 2015  Synaptics Inc. (NASDAQ: SYNA ), a ... it will report financial results for the fourth quarter ... after the close of market. The company will host ... 2:00 p.m. PT (5:00 p.m. ET), during which management ... on the live call, analysts and investors should dial ...
(Date:7/8/2015)... YORK , July 8, 2015  BD (Becton, ... BD & Guidepoint Mentor, a new program ... Guidepoint,s expert network services. BD is ... to improve healthcare delivery and outcomes and, with the ... entrepreneur will be able to directly engage with industry ...
(Date:7/7/2015)... OXFORD, Conn. , July 7, 2015 NXT-ID, Inc. ... company focused on the growing mobile commerce market announces a revised ... airing this week. The commercial will air on CNBC in ... Los Angeles and San Francisco ... The commercial focuses on Wocket,s ability to replace all the ...
Breaking Biology News(10 mins):Synaptics to Report Fourth Quarter, Fiscal Year 2015 Results on July 30 2BD and Guidepoint Team to Connect Healthcare Start-up Companies With Business and Scientific Experts 2BD and Guidepoint Team to Connect Healthcare Start-up Companies With Business and Scientific Experts 3Wocket Smart Wallet Commercials Airing on CNBC to Showcase This Summer's Must- Have Tech Product 2Wocket Smart Wallet Commercials Airing on CNBC to Showcase This Summer's Must- Have Tech Product 3
... tiny plants living in the ocean need iron for energy ... for one, they can,t exactly turn to natural iron ... So where does their iron come from? New research ... on the seafloor: minute particles (called nanoparticles) of pyrite, or ...
... and girls have put many of the trappings of teenagerhood behind ... some of the brain resculpting that characterizes the decade of adolescence ... in a new study that measured brainwaves of subjects in their ... kinds of neurological changes underway in a teen brain is a ...
... chemistry professors have invented a new polarimeter, a basic ... of transverse waves, such as light waves, that could ... has now patented the device. Certain compounds ... polarized light. Plane polarized light is light whose electric ...
Cached Biology News:As good as gold 2Study: Pace of brain development still strong in late teens 2Chemistry researchers receive patent for new scientific measurement instrument 2
KOR-1 (C-20)...
...
VAP-1 (S-13)...
... at the 3, 3', 4, and 4' ... an internal standard for the quantification of ... spectrometry. PGE2 is one of the primary ... of the most widely investigated prostaglandins. Its ...
Biology Products: